Search research articles
Contact Us
Filters
Showing results (31-40 of 187) with videos related to
Page
of 19
Sort By:
Journal of Cardiovascular Pharmacology
|
June 24, 2011
Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization
Thomas F Solbach, Markus Grube, Martin F Fromm, et al.
Metabolites
|
April 21, 2022
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact
Daniela B Surrer, Martin F Fromm, Renke Maas, et al.
Amino Acids
|
June 24, 2025
Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins
Lorenz A Scherpinski, Martin F Fromm, Renke Maas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 27, 2012
Effect of the rs168924 single-nucleotide polymorphism in the SLC6A2 catecholamine transporter gene on blood pressure in Caucasians
Oliver Zolk, Christian Ott, Martin F Fromm, et al.
Trends in Cardiovascular Medicine
|
January 3, 2006
ATP-binding cassette transporters in the heart
Thomas F Solbach, Jörg König, Martin F Fromm, et al.
Journal of Clinical Medicine
|
July 27, 2022
Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis
Melanie I Then, Wahram Andrikyan, Martin F Fromm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 3, 2009
Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser
Oliver Zolk, Thomas F Solbach, Jörg König, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 13, 2008
Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
Oliver Zolk, Thomas F Solbach, Jörg König, et al.
British Journal of Clinical Pharmacology
|
June 22, 2021
The CredibleMeds<sup>®</sup> list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information
Melanie I Then, Wahram Andrikyan, Renke Maas, et al.
Clinical Pharmacology and Therapeutics
|
July 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC
Michael I Sponfeldner, Wahram Andrikyan, Renke Maas, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 187) with videos related to
Sort By:
Page
of 19
Journal of Cardiovascular Pharmacology
|
June 24, 2011
Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization
Thomas F Solbach, Markus Grube, Martin F Fromm, et al.
Metabolites
|
April 21, 2022
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact
Daniela B Surrer, Martin F Fromm, Renke Maas, et al.
Amino Acids
|
June 24, 2025
Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins
Lorenz A Scherpinski, Martin F Fromm, Renke Maas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 27, 2012
Effect of the rs168924 single-nucleotide polymorphism in the SLC6A2 catecholamine transporter gene on blood pressure in Caucasians
Oliver Zolk, Christian Ott, Martin F Fromm, et al.
Trends in Cardiovascular Medicine
|
January 3, 2006
ATP-binding cassette transporters in the heart
Thomas F Solbach, Jörg König, Martin F Fromm, et al.
Journal of Clinical Medicine
|
July 27, 2022
Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis
Melanie I Then, Wahram Andrikyan, Martin F Fromm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 3, 2009
Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser
Oliver Zolk, Thomas F Solbach, Jörg König, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 13, 2008
Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
Oliver Zolk, Thomas F Solbach, Jörg König, et al.
British Journal of Clinical Pharmacology
|
June 22, 2021
The CredibleMeds<sup>®</sup> list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information
Melanie I Then, Wahram Andrikyan, Renke Maas, et al.
Clinical Pharmacology and Therapeutics
|
July 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC
Michael I Sponfeldner, Wahram Andrikyan, Renke Maas, et al.
Page
of 19